These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33691560)

  • 21. Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases.
    Chen Q; Shi Y; Chen Y; Ji T; Li Y; Yu L
    Gene; 2019 Feb; 684():47-52. PubMed ID: 30352248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.
    Klangkalya N; Stoddard J; Niemela J; Sponaugle J; Greenwell IB; Reigh E; Kuehn HS; Kanakry JA; Rosenzweig SD; Dimitrova D
    Clin Immunol; 2024 Mar; 260():109922. PubMed ID: 38320737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation.
    Shahin T; Mayr D; Shoeb MR; Kuehn HS; Hoeger B; Giuliani S; Gawriyski LM; Petronczki ÖY; Hadjadj J; Bal SK; Zoghi S; Haimel M; Jimenez Heredia R; Boutboul D; Triebwasser MP; Rialland-Battisti F; Costedoat Chalumeau N; Quartier P; Tangye SG; Fleisher TA; Rezaei N; Romberg N; Latour S; Varjosalo M; Halbritter F; Rieux-Laucat F; Castanon I; Rosenzweig SD; Boztug K
    Blood Adv; 2022 Apr; 6(7):2444-2451. PubMed ID: 34920454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IKZF1 (IKAROS) deletions in B-ALL and its clinical correlation: A prospective study from a tertiary care centre in Northern India.
    Gupta SK; Bakhshi S; Kumar L; Seth R; Kumar R
    Leuk Res; 2016 Feb; 41():7-11. PubMed ID: 26704074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Immune Thrombocytopenia Associated With a Novel Variant in
    Sriaroon P; Chang Y; Ujhazi B; Csomos K; Joshi HR; Zhou Q; Close DW; Walter JE; Kumánovics A
    Front Pediatr; 2019; 7():139. PubMed ID: 31069201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic germline
    Brodie SA; Khincha PP; Giri N; Bouk AJ; Steinberg M; Dai J; Jessop L; Donovan FX; Chandrasekharappa SC; de Andrade KC; Maric I; Ellis SR; Mirabello L; Alter BP; Savage SA
    Cold Spring Harb Mol Case Stud; 2021 Aug; 7(4):. PubMed ID: 34162668
    [No Abstract]   [Full Text] [Related]  

  • 27. Ikaros and leukaemia.
    Olsson L; Johansson B
    Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inborn errors of IKAROS and AIOLOS.
    Yamashita M; Morio T
    Curr Opin Immunol; 2021 Oct; 72():239-248. PubMed ID: 34265590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation.
    Hoshino A; Picard BH; Polychronopoulou S; Kelaidi C; Azarnoush S; Kracker S; Rieux-Laucat F; Boutboul D; Latour S
    J Allergy Clin Immunol; 2024 Jul; 154(1):229-236.e2. PubMed ID: 38438084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes.
    Swafford AD; Howson JM; Davison LJ; Wallace C; Smyth DJ; Schuilenburg H; Maisuria-Armer M; Mistry T; Lenardo MJ; Todd JA
    Diabetes; 2011 Mar; 60(3):1041-4. PubMed ID: 21270240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report:
    Äng C; Zetterström RH; Ramme K; Axelsen E; Marits P; Sundin M
    Front Immunol; 2023; 14():1257581. PubMed ID: 37771582
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
    Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?
    Hu SJ; Wen LL; Hu X; Yin XY; Cui Y; Yang S; Zhang XJ
    Mod Rheumatol; 2013 Mar; 23(2):205-9. PubMed ID: 22782532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifaceted roles of
    Feng L; Zhang H; Liu T
    Front Oncol; 2024; 14():1383419. PubMed ID: 38978740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: A Highly Variable Clinical and Immunological Presentation of IKAROS Deficiency in a Single Family.
    Kuijpers TW; Tromp SAM; van Leeuwen EMM; de Bree GJ
    Front Immunol; 2022; 13():865838. PubMed ID: 35479066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice.
    Ueta M; Hamuro J; Nishigaki H; Nakamura N; Shinomiya K; Mizushima K; Hitomi Y; Tamagawa-Mineoka R; Yokoi N; Naito Y; Tokunaga K; Katoh N; Sotozono C; Kinoshita S
    Allergy; 2018 Feb; 73(2):395-404. PubMed ID: 28914974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKZF1 Deletion Subtyping and Outcome Analysis in BCR-ABL1-Negative Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Institution Experience from North India.
    Gupta SK; Bakhshi S; Gupta R; Sharma P; Pushpam D; Sahoo RK; Kamal VK
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e666-e673. PubMed ID: 33906825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.
    Wagener R; Elitzur S; Brozou T; Borkhardt A
    Eur J Med Genet; 2023 Apr; 66(4):104725. PubMed ID: 36764385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.
    Goh W; Sudholz H; Foroutan M; Scheer S; Pfefferle A; Delconte RB; Meng X; Shen Z; Hennessey R; Kong IY; Schuster IS; Andoniou CE; Davis MJ; Hediyeh-Zadeh S; Souza-Fonseca-Guimaraes F; Parish IA; Beavis P; Thiele D; Chopin M; Degli-Esposti MA; Cursons J; Kallies A; Rautela J; Nutt SL; Huntington ND
    Nat Immunol; 2024 Feb; 25(2):240-255. PubMed ID: 38182668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.